Configurable clathrin light chain composition
OwnerFranco Vitaliano, Gordana Dragan Vitalianoinventors
Life of this patent
Estimating the term…
Abstract
The invention in suitable embodiments is directed to using a purified, clathrin light chain protein for purposes of drug development, enablement, activity, and/or delivery. In one aspect, a man-made, configurable clathrin light chain composition, formed in whole or in part from isolated, synthetic and or recombinant amino acid residues comprising in whole or in part one or more of a protein sequence, forms one or more type of multifunction nanoscale bio-nanoparticle, such as a biomedical platform, bio-molecular platform, and the like, and using such bio-nanoparticle platforms for development, enablement, and delivery of drugs.
Claims32
An isolated nanoparticle comprising:
- one or more of a man made clathrin light chain protein comprising at least one of a drug activity, and the preceding protein has an amino acid sequence of at least 50, 60, 70, 80, or 90% sequence identity when compared to SEQ ID NO:
- 12, and administering to a subject in need thereof the preceding composition or protein, wherein the patient is treated for at least one of a disease, condition, or disorder.
A method for an isolated nanoparticle comprising:
- one or more of a man made clathrin light chain protein comprising at least one of a drug activity, and the preceding protein has an amino acid sequence of at least 50, 60, 70, 80, or 90% sequence identity when compared to SEQ ID NO:
- 12, and administering to a subject in need thereof the preceding composition or protein, wherein the patient is treated for at least one of a disease, condition, or disorder.
Dependencies are inferred from the claim text.